Background -The role of -251A>T polymorphism in the anti-inflammatory cytokine interleukin-8 (IL-8) gene in gastric cancer was intensively evaluated, but the results of these studies were inconsistent. Objective -Therefore, we performed a meta-analysis to provide a comprehensive data on the association of IL-8 -251T>A polymorphism with gastric cancer. Methods -All eligible studies were identified in PubMed, Web of Science, EMBASE, Wanfang and CNKI databases before September 01, 2019. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were derived from a fixed effect or random effect model. Results -A total of 33 case-control studies with 6,192 cases and 9,567 controls were selected. Overall, pooled data showed that IL-8 -251T>A polymorphism was significantly associated with an increased risk of gastric cancer under all five genetic models, i.e., allele (A vs T: OR=1.189, 95% CI 1.027-1.378, P=0.021), homozygote (AA vs TT: OR=1.307, 95% CI 1.111-1.536, P=0.001), heterozygote (AT vs TT: OR=1.188, 95% CI 1.061-1.330, P=0.003), dominant (AA+AT vs TT: OR=1.337, 95% CI 1.115-1.602, P=0.002) and recessive (AA vs AT+TT: OR=1.241, 95% CI 1.045-1.474, P=0.014). The stratified analysis by ethnicity revealed an increased risk of gastric cancer in Asians and mixed populations, but not in Caucasians. Moreover, stratified by country found a significant association in Chinese, Korean and Brazilian, but not among Japanese. Conclusion -This meta-analysis suggests that the IL-8 -251T>A polymorphism is associated with an increased risk of gastric cancer, especially by ethnicity (Asian and mixed populations) and country (Chinese, Korean and Brazilian). HEADINGS -Stomach neoplasms. Interleukin 8. Genetic polymorphism. Meta-analysis.
INTRODUCTION
Gastric cancer is the 4th most common malignancy and the second leading cause of cancer-related death worldwide (1, 2) , accounting for more than one million new patients and an estimated 783,000 deaths in 2018 (3) . There is considerable variation in gastric cancer incidence rates according to age, gender, socioeconomical factors and geographical location (4) . Several factors have been suggested as risk factors for gastric cancer, which by establishing complex interactions may ultimately lead to development of this disease. The exact etiology of gastric cancer is multifactorial and both host genetic variants and environmental factors, including inflammation, Helicobacter pylori (H. pylori) infection, cigarette smoking, alcohol consumption, dietary and nutritional aspects have been shown to play a role in the development of this disease (5, 6) .
Interleukin-8 (IL-8, also known as CXCL8) is a member of the alpha (C-X-C) subfamily of small basic heparin-binding chemokines (7) . These group of proteins are proinflammatory and primarily mediate the activation and migration of neutrophils into tissue from peripheral blood (8) . IL-8 was originally discovered and purified as a neutrophil chemotactic and activating factor and secreted by several hematopoietic cells, fibroblasts, hepatocytes, and Association of IL-8 -251T>A (rs4073) polymorphism with susceptibility to gastric cancer: a systematic review and meta-analysis based on 33 case-control studies Mansour MOGHIMI 1 , Seyed Alireza DASTGHEIB 2 , Naeimeh HEIRANIZADEH 3 , Mohammad ZARE 3 , Elnaz SHEIKHPOUR 4 and Hossein NEAMATZADEH 5, 6 various cell lines and interacts with two specific seven-transmembrane span, G-protein-coupled receptors, CXCR1 and CXCR2 (9, 10) . Moreover, IL-8 is produced by several types of tumor cells and has been shown to be involved in angiogenesis and neovascularizationdependent tumor growth (11) . Hence, IL-8 gene variants may be the important determinants of development of different cancers, especially gastric cancer. IL-8 is associated with both the immune response and the inflammatory process against H. pylori (12) . An increased IL-8 expression has been detected in patients with H. pylori infection and gastric disorders (12, 13) .
The human IL-8 gene is mapped to 4q12-q21 by somatic cell hybridization and in situ hybridization, spanning 5.2 kb in length and contains 10 exons (14) . The 3' untranslated region (UTR) of IL-8 contains a A/U-rich element that makes it extremely unstable under certain conditions. The -251T>A (rs4073) polymorphism in the IL-8 promoter is one of the most extensively studied genetic variant in several inflammatory conditions (15) . Although several studies have been previously performed to evaluate whether the IL-8 -251T>A (rs4073) polymorphism increases the risk of gastric cancer, the results from these studies are inconsistent and controversial. Therefore, this study aimed to perform a meta-analysis including the update data to evaluate the association of IL-8 -251T>A (rs4073) polymorphism and gastric cancer. 2/9 • Arq Gastroenterol • 2020 [ahead of print]
METHODS

Search strategy
We have performed this meta-analysis in adherence with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A comprehensive literature search was conducted in PubMed, EMBASE, Cochrane Library database, SID, CBM, WanFang Chinese Biomedical Database (CBD), China National Knowledge Infrastructure (CNKI) and VIP database to collect all the eligible studies evaluating the association of IL-8 -251T>A (rs4073) polymorphism and gastric cancer until to September 01, 2019. The following terms, keywords and their combinations were used: ("gastric'' OR "stomach'') AND ("cancer'' OR "malignancy'' OR "tumor'' OR "carcinoma'' or "neoplasm'' OR "adenocarcinoma'') AND ("interleukin-8'' OR "IL-8'' OR "C-X-C motif chemokine ligand 8'' OR "CXCL8'' OR "neutrophil chemotactic factor'') AND ("polymorphism'' OR "SNP'' OR "variant'' OR "genotype'' OR "mutation'' OR "allele''). The whole search process was carried out in English, Chinese and Farsi. Ethical approval was not necessary since this study was based on previous publications.
Inclusion and exclusion criteria
The studies were considered eligible if the following criteria are met: 1) studies with case-control and cohort design; 2) studies were performed on human beings; 3) studies evaluated the association between the IL-8 -251T>A polymorphism and gastric cancer; and 4) provide adequate data to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Studies were excluded if one of the following criteria was fulfilled: 1) studies that had no control group; 2) abstracts, review, letters, comments, conference presentations, case reports or case series; 3) studies without detailed raw data regarding IL-8 -251T>A polymorphism; 4) family-based, sibling, twins and linkage studies. For duplicate reports, only the study with the largest sample size was included.
Data extraction
All the available data were extracted from each study by two of the authors independently and carefully according to the criteria and any disagreement was resolved by discussion with third author. For each included study, the following information was collected: first author's name, year of publication, ethnicity (Asian, Caucasian, African and mixed populations), country of origin, source of the controls (hospital based or population based), genotyping methods, numbers of cases and controls, frequencies of genotypes in cases and controls, minor allele frequency (MAF) in controls, and Hardy-Weinberg equilibrium (HWE) in controls. The ''mixed'' group means mixed or unknown populations. When studies included sample of more than one ethnicity or population, the data was extracted separately according to ethnicities. If necessary data were not reported in the primary manuscripts, we contacted the corresponding authors by email to request the missing data.
Methodological quality assessment
Quality assessments for eligible studies were conducted by two investigators independently using the Newcastle-Ottawa Scale (NOS). In this methodological quality assessment scale, nine items, each with a score value between one and nine, are included. The NOS has a score range of zero to nine, and studies with a NOS score of ≥6 stars is generally considered of high-quality.
Statistical analysis
The strength of association between IL-8 -251T>A poly-morphism and gastric cancer was assessed by odds ratios (ORs) with 95% confidence intervals (95% CIs). The significance of the pooled effect size was determined by Z-test, in which P<0.05 was considered statistically significant. The association was evaluated in five genetic models, i.e., allele (A vs T), homozygote (AA vs TT), heterozygote (AT vs TT), dominant (AA+AT vs TT), and the recessive (AA vs AT+TT). Between-study heterogeneity was evaluated by the Cochran Q-test, in which P≤0.10 indicated significant heterogeneity was found. In addition, the I 2 statistic we applied to qualify between-study heterogeneity (range of 0 to 100%: I 2 =0-25%, no heterogeneity; I 2 =25%-50%, moderate heterogeneity; I 2 =50%-75%, large heterogeneity; I 2 =75%-100%, extreme heterogeneity). The random effects model shows more flexibility with respect to variable effect size in different studies and study populations. Thus, we have applied a random-effects model, using the DerSimonian and Laird method to calculate the pooled OR when heterogeneity was found; otherwise, affixed effect model was applied to use the Mantel-Haenszel method in absence of heterogeneity. A Hardy-Weinberg equilibrium (HWE) test in controls was tested using chi-square test (P-values <0.05). Subgroup analyses were conducted by stratification of ethnicity to identifying potential source of heterogeneity. Sensitivity analyses were performed to assess influence of each single study on pooled ORs and the stability of the meta-analysis results by sequential remove of individual studies. In addition, sensitivity analysis by excluding those studies HWE violating was performed to examine the stability of the results. Funnel plots and Egger's linear regression test were used to estimate evidence for potential publication bias. All of the statistical calculations were performed using Comprehensive Meta-Analysis (CMA) software version 2.0 (Biostat, USA). Two-sided P-values <0.05 were considered statistically significant. quently excluded because not reporting useful data for meta-analysis, review, case only study, and not being case-control studies. Finally, a total of 33 eligible studies with 6,192 gastric cancer cases and 9,567 controls were included in the meta-analysis . Characteristics of included studies are shown in TABLE 1. All eligible studies were published in English and Chinese. The NOS score of included studies ranged from 7 (19 studies) to 8 (14 studies), which suggested that all included studies were of relatively high quality. Among them, 21 studies were based on Asians (Taiwan, Japan, Korea, Iran, and India), seven based on Caucasians (USA, Finland, France, Portugal, Hungary, Romanian), and five were based on mixed populations (Mexico and Brazil). The allele, genotype and minor allele frequency (MAF) distributions in the cases and controls are shown in TABLE 1. Moreover, the distribution of genotypes in the controls was in agreement with Hardy-Weinberg equilibrium (HWE) for all selected studies, except for one study (TABLE 1) .
RESULTS
Characteristics of selected studies
Overall and subgroup analyses
The summary of the meta-analysis of the association of between IL-8 -251T>A polymorphism and gastric cancer are shown in TABLE 2. Overall, pooled ORs showed that there was a significant association between IL-8 -251T>A polymorphism and gastric can- P≤0.001, FIGURE 2D ; and AA+AT vs TT: OR=1.360, 95% CI 1.026-1.803, P=0.033), but not in Japanese. When stratified by source of controls, the results showed a significant association between IL-8 -251T>A polymorphism and gastric cancer in hospital based studies (AA vs TT: OR=1.402, 95% CI 1.117-1.760, P=0.004; AT vs TT: OR=1.346, 95% CI 1.150-1.576, P≤0.001; and AA+AT vs TT: OR=1.397, 95% CI 1.158-1.684, P≤0.001) and population based studies (AA vs AT+TT: OR=1.407, 95% CI 1.020-1.941, P=0.038). Subgroup analysis by genotyping methods revealed that there was a significant association between IL-6 -176G>C polymorphism and gastric cancer risk in PCR-RFLP group of studies (AT vs TT: OR=1.248, 95% CI 1.113-1.400, P=0.001; and AA+AT vs TT: OR=1.250, 95% CI 1.065-1.467, P=0.006) and in group of studies used other genotyping methods (A vs T: OR=1.370, 95% CI 1.049-1.789, P=0.021; AA vs TT: OR=1.457, 95% CI 1.167-1.822, P=0.001; AA+AT vs TT: OR=1.494, 95% CI 1.048-2.131, P=0.027; and AA vs AT+TT: OR=1.531, 95% CI 1.134-2.067, P=0.005). 
B C D Between-study heterogeneity
There was statistically moderate to high heterogeneity among the studies under all five genetic models, i.e., allele (I 2 =87.85, P H ≤0.001), homozygote (I 2 =55.20, P H ≤0.001), heterozygote (I 2 =50.86, P H ≤0.001), dominant (I 2 =83.25, P H ≤0.001), and recessive (I 2 =69.17, P H ≤0.001) in overall population. To explore the sources of heterogeneity, we performed subgroup analyses using ethnicity, country, source of controls and genotyping methods. The results suggested that ethnicity and country (population) may contribute to the heterogeneity in this meta-analysis.
Sensitivity analysis
To evaluate the sensitivity of the meta-analysis, we omitted each study at a time and checked for significant differences. There were no significant differences observed upon removal of any of the studies, indicating that our results are statistically reliable and stable. Deviation of HWE may reflect methodological problem such as genotyping errors, population stratification or selection bias. Moreover, we performed sensitivity analysis by excluding the HWE-violating study. When this study was excluded, the results were not changed in overall population and also by subgroup analyses, indicating that our meta-analysis was statistically robust and reliable.
Publication bias
Publication bias was assessed with Begg's funnel plots and Egger's test (TABLE 2) Thus, we utilized the trim-and-fill method developed by Duval and Tweedie to adjust these biases. However, after trimming we have yield similar results, indicating that the results were statistically reliable.
DISCUSSION
In this meta-analysis, we included 33 case-control studies with 6,192 cases and 9,567 controls about association between IL-8 -251T>A polymorphism and gastric cancer. Our pooled data showed that there was a significant association between IL-8 -251T>A polymorphism and gastric cancer under all five genetic models. Our subgroup meta-analysis also demonstrates that the IL-8 -251T>A polymorphism was associated with gastric cancer in Asians and mixed populations. Moreover, the IL-8 -251T>A polymorphism is associated with gastric cancer in Chinese, Korean and Brazilian. Although, meta-analyses have revealed evidence that IL-8 -251T>A polymorphism is associated with significantly increased risk of gastric cancer in overall analyses, none reported the association between IL-8 -251T>A polymorphism in mixed population and by country.
In 2015, Zhang et al., in meta-analysis of 26 studies with 5286 cases and 8000 controls have evaluated association between IL-8 -251T>A polymorphism and gastric cancer (40) . Their results showed that IL-8 -251T>A polymorphism was significantly associated with increased risk of gastric cancer. Similarly, they have found that this polymorphism was associated with gastric cancer in Asians, but not in Caucasians. However, inconsistence with our pooled data, their results failed to show an association in PCR-RFLP studies. In 2018, Wang et al., in a meta-analysis of 31 studies with 5848 cases and 8926 controls have evaluated of IL-8 -251T>A polymorphism with gastric cancer (41) . Their results showed a significant association between IL-8 -251T>A polymorphism and gastric cancer risk in overall and in Asians. However, their pooled data were based on crude pooled ORs, not adjusted OR values such as genotyping methods and source of controls, which might be caused to inaccurate results. Our results seem to confirm and establish the trend in the meta-analysis of association between IL-8 -251T>A polymorphism and gastric cancer risk that the data by previous meta-analyses had indicated. Moreover, the previous meta-analyses have not performed subgroup analysis by ethnicity in mixed populations and by country. Although, our subgroup analysis showed that IL-8 -251T>A polymorphism with gastric cancer, there was no significant association in Japanese. It is suggested that the lack of an increased risk of gastric cancer in Japanese might be attributing to genetic backgrounds and environmental factors of the population. In addition, other factors such as gene-gene interactions may be modulating the IL-8 -251T>A polymorphism functionality in Japanese populations.
The possibility of publication bias in a meta-analysis is always a concern, especially when the number of incorporated studies is small (42) (43) (44) . Although, large number of studies included in this meta-analysis, publication bias have distorted our results. It seems the studies that found any negative results of the association between IL-8 -251T>A polymorphism with gastric cancer may not have been published. Moreover, heterogeneity and confounding factors may have affected the meta-analysis. In this meta-analysis, there was a mild to high between-study heterogeneity under all five genetic models that could affect our results. This may be attributed to variations in confounding factors such as age, gender, source of controls, tumor stage, pathological type, and genotyping method (45) (46) (47) . We were unable to take most of these confounders into consideration in our meta-analysis because the majority of studies either did not report these baseline data. However, subgroup analyses by ethnicity, country, source of controls and genotyping methods revealed that ethnicity and country (population) may contribute to the heterogeneity in this meta-analysis. Our meta-analysis has several strengths. First, a systematic review of the association of IL-8 -251T>A polymorphism with gastric cancer risk is statistically more powerful than any previous meta-analysis. Second, the quality of eligible studies included in this meta-analysis was satisfactory and met the inclusion criterion. Although, we performed a comprehensive meta-analysis with several subgroup analyses, there were still several limitations to be taken into consideration in this meta-analysis. First, we only selected published studies electronically in some databases, so it is possible that some pertinent studies not included in these databases or unpublished studies with negative results may have been missed. Second, only small numbers of studies were included in some subgroups such as subsets of studies among Caucasians and TaqMan. Therefore, these subgroup analyses may not have enough statistical power with the small sample size and the conclusions must be interrupted by caution. Third, although the overall sample size is large, the size of study performed in Caucasians mixed populations was relatively small. Therefore, more studies in Caucasians mixed populations are required in other populations. Finally, the mechanism of gastric cancer is considered to be sophisticated, including gene-gene and gene-environment interactions. More studies with enough statistical power are needed for deeply evaluation.
In summary, this meta-analysis suggested that the IL-8 -251T>A polymorphism might contribute to susceptibility and development of gastric cancer in overall population, especially in Asians and mixed populations. Moreover, there was a significant association between IL-8 -251T>A polymorphism and an increased risk of gastric cancer in Chinese, Korean and Brazilian populations. However, it is necessary to conduct large sample studies using standardized unbiased genotyping methods, homogeneous cancer patients and well-matched controls. Moreover, further studies estimating the effect of gene-gene and gene-environment interactions may eventually lead to our better, comprehensive understanding of the association between IL-8 -251T>A polymorphism and gastric cancer risk.
